While millions of people worldwide are battling against COVID-19, fortunately, the vast majority of patients who get infected will overcome the disease and survive.
On April 1, the first patient who recovered from Covid-19 donated plasma at the Magen David Adom (MDA) Blood Services Center at Sheba Medical Center.
The current pandemic poses a variety of new challenges to all healthcare professionals and facilities, including clinicians and researchers. In response, governments, including that of Israel, have enlisted high tech companies to assist in the battle against Covid-19.
Introducing Sheba’s Critical Care Corona Unit
The head of Sheba Medical Center’s Infectious Disease unit, Professor Gili Regev-Yochay, speaks with Steve Walz, our international spokesperson, about Sheba’s new Critical Care Corona Unit (CCCU) underground complex.
Approximately two months after coronavirus COVID-19 broke out in China, the country has almost succeeded in halting the epidemic.
A compact blood analyzer developed by an Israeli blood testing startup has been implemented to support the healthcare management of coronavirus-infected patients.
Proactive, detailed planning helped Sheba to confront the different hurdles involved in dealing with coronavirus. “We had a full drill a month before the first coronavirus patient was diagnosed in Israel,” Walz said.
Sheba Medical Center pushes forward with digital healthcare, embracing telemedicine to monitor patients in quarantine and treat patients with coronavirus COVID-19 remotely.
Prof. Gideon Rechavi, world-renowned doctor and head of Sheba Medical Center’s Cancer Research Center, has been designated to receive the prestigious Israel Prize for Medical Science at a special ceremony to be held on April 20.
Lung cancer is the type of cancer that leads to the highest mortality rate in men and the third highest in women.
CONTACT OUR MEDICAL TOURISM DIVISION
Established in 1948, Sheba Medical Center is now the leading medical center in the region.